I’ve received a number of emails in the form further below.
I do appreciate the acknowledgement of this change, which I did advocate for. It makes a lot of sense — oral cancer therapies are often safer and more cost-effective than intravenous therapies.
As a constituent and a volunteer for the American Cancer Society Cancer Action Network, I want to thank you for helping make Massachusetts the 21st state to pass an oral chemotherapy parity law!
The bill, S. 2363, An Act Relative to Oral Cancer Therapy, which became law after bi-partisan support on Beacon Hill, will require coverage for orally administered cancer medications equivalent to that of intravenous (IV) therapies.
With medical advancements making some chemotherapy safer, more effective and in many cases less costly, this law will go a long way toward improving the lives and outcomes of cancer patients and their families. Thanks to you, cancer patients will have affordable access to the most effective treatment regardless of how the chemotherapy is administered.